Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Plans For Soy Health Claims, Pyridoxamine's Use Questioned By CRN, NPA

Mar 21 2018

• By Malcolm Spicer

Compliance

Related Content

FDA Touches Constitutional Nerve In Warning On Mixing Supplements, Drugs – NPA

Nov 06 2014

Pyridoxamine Petition Paints Better Option As Dietary Ingredient Than IND

Nov 16 2017

Industry Eyes NDI Notification Common Ground With Gottlieb-Led FDA

Jun 08 2017

FDA Doubts 'Certainty' Of Soy Heart Benefit In First Health Claim Revocation

Oct 31 2017

Additional Topics

United States International Dietary Supplements FDA Regulation Consumer

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window